![](/img/cover-not-exists.png)
Evaluation of FASN inhibitors by a versatile toolkit reveals differences in pharmacology between human and rodent FASN preparations and in antiproliferative efficacy in vitro vs. in situ in human cancer cells
Singha, Prosanta K., Mäklin, Kiira, Vihavainen, Taina, Laitinen, Tuomo, Nevalainen, Tapio J., Patil, Mahadeo R., Tonduru, Arun K., Poso, Antti, Laitinen, Jarmo T., Savinainen, Juha R.Volume:
149
Journal:
European Journal of Pharmaceutical Sciences
DOI:
10.1016/j.ejps.2020.105321
Date:
June, 2020
File:
PDF, 1.96 MB
2020